Template:Artemether lumefantrine: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 19: Line 19:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Artemether lumefantrine overdosage|Overdosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Artemether lumefantrine overdosage|Overdosage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Artemether lumefantrine clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Artemether lumefantrine dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Artemether lumefantrine dosage and administration|Dosage and Administration]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Artemether lumefantrine compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Artemether lumefantrine how supplied|How Supplied]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Artemether lumefantrine how supplied|How Supplied]]

Latest revision as of 22:31, 6 January 2014